Taikang Life Insurance appeared to be the Corporate Investor, which was created in 1996. The leading representative office of defined Corporate Investor is situated in the Beijing. The fund was located in Asia if to be more exact in China.
For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular portfolio startups of the fund, we may highlight EasyHome, Innovent Biologics, Womai. Among the most popular fund investment industries, there are Biotechnology, Biopharma. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups.
Besides them, we counted 2 critical employees of this fund in our database.
The fund is generally included in 2-6 deals every year. The top amount of exits for fund were in 2019. Considering the real fund results, this Corporate Investor is 9 percentage points more often commits exit comparing to other organizations. This Taikang Life Insurance works on 14 percentage points more the average amount of lead investments comparing to the other organizations. The common things for fund are deals in the range of more than 100 millions dollars. The average startup value when the investment from Taikang Life Insurance is more than 1 billion dollars. The high activity for fund was in 2019.
The usual cause for the fund is to invest in rounds with 5-6 partakers. Despite the Taikang Life Insurance, startups are often financed by Lilly Asia Ventures, F-Prime Capital, Temasek Holdings. The meaningful sponsors for the fund in investment in the same round are Temasek Holdings, Lilly Asia Ventures, Legend Capital. In the next rounds fund is usually obtained by Temasek Holdings, Hillhouse Capital Group, Lilly Asia Ventures.
|Cordaid Investment Management||The Hague, The Netherlands, Zuid-Holland|
|Delin Capital||England, London, United Kingdom|
|eLong.com||Beijing, Beijing, China|
|First European American Ventures||-|
|Gansu Guotou||China, Shanghai|
|H&S Ventures||California, Corona Del Mar, United States|
|Innovation Ventures||Delaware, United States, Wilmington|
|ITFC||England, London, United Kingdom|
|Mars Petcare||Belgium, Brussels, Brussels Hoofdstedelijk Gewest|
|Moser Baer||Delhi, India, New Delhi|
|MVC Capital||New York, Purchase, United States|
|Northwest Regional Development Agency||England, United Kingdom, Warrington|
|OAS Corp.||Japan, Tokyo|
|Seaboard Ventures||Charleston, South Carolina, United States|
|Shanghai Weixu Investment Management||China, Shanghai|
|Texas Growth Fund||Austin, Texas, United States|
|The Allana Group||India, Maharashtra, Mumbai|
|The Luxembourg Future Fund||Luxembourg, Luxembourg|
|XY Capital||China, Hangzhou, Zhejiang|
|Zhuhai Pude Equity Investment Management||China, Guangdong, Zhuhai|
|$15M||04 Mar 2022||Shanghai, China|
|$31M||14 Dec 2021||Dongcheng District, Beijing, China|
|$30M||19 Nov 2021||-|
|$2B||19 May 2021||Yangzhou, Jiangsu, China|
GitLab Information Technology (Hubei) Co., LTD
|18 Mar 2021||Beijing, Beijing, China|
|$154M||20 Oct 2020||Dongcheng District, Beijing, China|
|$200M||24 Sep 2020||Futian District, Guangdong Province, China|
|$77M||06 Jul 2020||Futian District, Guangdong Province|
|$170M||09 Sep 2019||China, Beijing|
4. We can moderate comments at any time.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.